Clinres Farmacija
Acquisition in 2023
Clinres Farmacija is a contract research organization (CRO) specializing in outsourcing clinical trials and related business processes. The company offers a range of services that include legal representation, data management, strategic solutions, feasibility studies, clinical monitoring, and medical writing. By leveraging its expertise, Clinres Farmacija aims to assist pharmaceutical companies and medical professionals in optimizing resource allocation and minimizing associated risks, thereby enhancing the efficiency of clinical development.
Kateric
Acquisition in 2022
Kateric is a specialized service provider that collaborates with international biopharmaceutical businesses to deliver comprehensive solutions for the creation of regulatory documents. The company offers outsourced medical writing and clinical trials disclosure support throughout the product lifecycle. Kateric's services include clinical trial disclosure, data anonymization, transparency initiatives, document redaction, medical writing and editing, as well as quality control review. These offerings provide end-to-end management and support to pharmaceutical companies, ensuring that all regulatory requirements are met efficiently.
OneSource Regulatory
Acquisition in 2022
OneSource Regulatory is a leading provider of medical regulatory services tailored for the healthcare industry. They specialize in designing and implementing regulatory strategies that create value and efficiencies for their clients throughout the product development and commercial lifecycle. Their comprehensive suite of services includes pre- and post-approval regulatory support, along with medical and marketing operations assistance, enabling clients to uphold and expand their brand presence effectively.
M Squared Associates
Acquisition in 2022
M Squared Associates is a respected clinical, regulatory, and quality consulting firm that serves medical technology organizations both in the United States and internationally. The company specializes in devices, biologics, and combination products across various therapeutic areas and disease spaces. It partners with a diverse array of clients, from start-ups to established multinational manufacturers, offering comprehensive strategic solutions to navigate complex regulatory challenges. M Squared Associates is recognized for its expertise in guiding innovative technologies from initial concept through to market introduction, ensuring compliance and successful deployment in the medical technology sector.
The Planet Group
Acquisition in 2021
The Planet Group is a diversified professional services organization that specializes in providing outsourced human capital solutions and consulting services. It serves multiple industries, including life sciences, energy and engineering, healthcare, and digital marketing. The company offers a comprehensive array of services such as professional staffing, recruitment process outsourcing, executive search, and managed services. Additionally, The Planet Group delivers various channel software solutions, ranging from on-demand offerings to fully managed outsourced services, tailored to meet the specific needs of its clients.
Diamond Pharma Services
Acquisition in 2021
Diamond Pharma Services is a consulting firm that specializes in providing technical, strategic, and scientific services to the biotechnology and pharmaceutical industries. The company offers expertise in regulatory affairs, pharmacovigilance, and compliance and quality assurance. These services support clients in obtaining and maintaining medicinal product licenses throughout all stages of a product's life cycle. By focusing on these critical areas, Diamond Pharma Services helps ensure that its clients meet necessary regulatory requirements and maintain high standards of safety and efficacy for their pharmaceutical products.
Southwood Research
Acquisition in 2019
Southwood Research Ltd is a life sciences consultancy based in Beaconsfield, United Kingdom, specializing in pre-approval regulatory science services for the pharmaceutical and biotech industries. Founded in 2016, the company focuses on delivering strategic clinical and regulatory insights to help clients navigate the complexities of product development. Southwood Research provides a range of services, including regulatory strategy, management, and the design and management of clinical research programs. By leveraging its expertise, the company aims to assist clients in shortening their time to market, ensuring compliance with regulatory requirements while optimizing their product development processes. As of March 2019, Southwood Research operates as a subsidiary of ProPharma Group, Inc.
The Weinberg Group
Acquisition in 2019
The Weinberg Group Inc. is a scientific and regulatory consulting firm based in Washington, D.C., specializing in helping companies navigate complex regulatory landscapes across various industries, including pharmaceuticals, biotechnology, medical devices, chemicals, consumer products, food, and cosmetics. Founded in 1983, the company provides a broad range of services, including regulatory compliance, quality systems management, and product advocacy. It assists clients in addressing regulatory requirements, improving manufacturing processes, and supporting products in legal contexts and public perception. The Weinberg Group also offers expertise in epidemiology, biostatistics, clinical pharmacology, biopharmaceutics, applied toxicology, and risk management, empowering clients to build scientific arguments that enhance product viability in the marketplace. Its extensive experience enables companies to develop efficient drug development pathways and navigate compliance challenges on a global scale. As a subsidiary of ProPharma Group, Inc., The Weinberg Group maintains a significant presence in the regulatory consulting sector.
Xendo B.V. is a consultancy and project management organization that specializes in the life sciences, pharmaceutical, and healthcare sectors. Established in 2000 and based in Leiden, the Netherlands, with an additional office in Berlin, Germany, the company delivers a range of services including health care product development, manufacturing, regulatory affairs, compliance, and engineering. Xendo offers bioprocessing services, regulatory affairs strategy, program management, and validation services, as well as engineering support such as plant design and maintenance. The company serves a diverse clientele, including biopharmaceutical companies, medical device manufacturers, hospitals, and laboratories, both domestically and internationally. Formerly known as Univalid Holding B.V., Xendo has been operating as a subsidiary of ProPharma Group, Inc. since 2018.